• #Digital Technology
• #Open Innovation
• #Co-Creation

CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance

Chugai Pharmaceutical’s CHUGAI INNOVATION DAY 2024 was hosted on November 25 (Mon) and 26 (Tue), 2024. This was the fifth hosting of the CHUGAI INNOVATION

• Innovation
• R&D
• DX
• Event

• #Sustainability

Corporate Growth Through Employee Health: Health and Productivity Management Alongside Employees to Create Platforms for Innovation and Working Environments for Peace of Mind

Chugai Pharmaceutical contributes to the health of people across the world through its innovative pharmaceuticals and services. Essential to fulfilling this

• Sustainability
• Human Resources
• Health and Productivity Management

• #Digital Technology
• #Co-Creation

Takao Suzuki was previously an employee at Microsoft where he supported numerous companies as director of the DX strategy advisory department. He now works as Head of the DX Unit at Chugai Pharmaceutical. According to Suzuki, what are the key factors to ensuring the successful implementation of DX?

Aiming to become the top innovator in the healthcare industry, Chugai Pharmaceutical has positioned DX as a fundamental element of its growth strategy. Phase 1

• Innovation
• DX
• CHUGAI DIGITAL VISION 2030
• Top Interview

• #Science and Technology
• #Digital Technology
• #Sustainability

Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals

Chugai Pharmaceutical is currently promoting companywide DX to achieve the targets of its new growth strategy Top I 2030. The company is focusing on innovative

• Innovation
• R&D
• DX
• Sustainability
• CHUGAI DIGITAL VISION 2030
• Production Technology

• #Science and Technology

Working to Reform the Drug Discovery Process—Acceleration of Drug Discovery Research Using Cryo-EM

Torizawa is general manager of the Protein Science Research Department. He is currently in charge of the early stages of drug discovery to uncover molecules

• Innovation
• R&D
• Cryo-Electron Microscopy

• #Science and Technology
• #Digital Technology

Working Toward Greater Efficiency in the Drug Discovery Process for Mid-size Molecules. Development of a Crystallization Confirmation App Using Agile Development Methods

Agile development has recently been garnering attention as a method that involves quickly ascertaining needs and progressing with a project in an agile and

• Innovation
• R&D
• DX
• Mid-Molecule Pharmaceuticals

• #Business Models
• #Digital Technology

Supporting the transformation of business with global-standard systems infrastructure. Stories from behind the scenes of the ERP system renewal project and the sense of reward that it gives, as discussed by staff working on the next-generation core business (ERP) system

With the promotion of DX, expectations are growing for the appropriate use of information about companies’ management resources. At Chugai Pharmaceutical

• R&D
• DX
• Recruitment
• IT Infrastructure

• #Business Models
• #Digital Technology

Leading the optimization of ICT infrastructure. Making advanced solutions a strength in Chugai Pharmaceutical’s business transformation

Sasaki is a member of the IT Solution Department. As Group Manager of a group that is responsible for applications used in the R&D field, from introduction

• DX
• Recruitment
• IT Infrastructure

• #Science and Technology
• #Digital Technology

Next-generation pharmaceutical lead by digital technology Taking on innovative drug development with a data-driven approach

The Pharmaceutical Technology Division is in charge of the development process leading to the commercialization of candidate molecules. Within that division,

• R&D
• DX
• Recruitment
• Drug Discovery Modalities
• Production Technology

• #Business Models
• #Digital Technology

Supporting DX with substantive risk management. To take the lead in cybersecurity to realize word-class drug discovery

Concurrently with its promotion of digital transformation (DX), Chugai Pharmaceutical is strengthening cybersecurity measures for the entire Group, including

• DX
• Recruitment
• Supply Chain Management
• Cybersecurity

• #Science and Technology

From the medical frontlines to a pharmaceutical company. Medical doctors leveraging their clinical experience to contribute to the creation of pharmaceuticals

Chugai Pharmaceutical, with its R&D bases and global development functions in Japan, has strived to conduct clinical studies based on medical grounds and

• Innovation
• R&D
• Recruitment
• Human Resources

• #Science and Technology
• #Sustainability
• #Co-Creation

To become a top runner in drug production. Taking on the challenge of innovative drug manufacturing with next-generation manufacturing facilities

Chugai Pharmaceutical’s bio drug substance (DS) manufacturing facility “UK4,” which contributes to the realization of sustainable global

• R&D
• Recruitment
• Sustainability
• Supply Chain Management
• Drug Discovery Modalities
• Production Technology

• #Sustainability

People are the source of innovation. The passion behind the development programs that envision, enhance and enable excellence of individuals

Chugai Pharmaceutical has set forth a new growth strategy, “TOP I 2030” in its bid to become a top global innovator. In the belief that our people

• Recruitment
• Human Resources

• #Sustainability
• #Co-Creation

The Bio Lab’s Development of the Next Generation of Scientists

One of Chugai Pharmaceutical’s research centers is the Chugai Life Science Park Yokohama in Totsuka-ku, Yokohama City. Within this center is the BIO LAB,

• Sustainability
• Social Contribution
• Bio Lab

• #Sustainability

There Is No Point in Producing Medicine in a World in Which People Cannot Live - Chugai’s Approach to Global Environmental Protection

The Chugai Pharmaceutical Group considers global environmental protection to be an important foundation for all its business activities, and has set three

• Global Environment
• Supply Chain Management